CanSino Biologics Statistics
Total Valuation
CASBF has a market cap or net worth of 2.32 billion. The enterprise value is 2.12 billion.
| Market Cap | 2.32B |
| Enterprise Value | 2.12B |
Important Dates
The last earnings date was Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 132.67M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.65% |
| Shares Change (QoQ) | +33.61% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 159.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 113.54 |
| PS Ratio | 17.93 |
| PB Ratio | 3.38 |
| P/TBV Ratio | 3.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 284.89 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -90.99 |
| EV / Sales | 16.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -56.12 |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.39.
| Current Ratio | 2.57 |
| Quick Ratio | 2.32 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.98 |
| Interest Coverage | -4.73 |
Financial Efficiency
Return on equity (ROE) is -3.35% and return on invested capital (ROIC) is -2.21%.
| Return on Equity (ROE) | -3.35% |
| Return on Assets (ROA) | -1.96% |
| Return on Invested Capital (ROIC) | -2.21% |
| Return on Capital Employed (ROCE) | -4.13% |
| Revenue Per Employee | 115,834 |
| Profits Per Employee | -20,907 |
| Employee Count | 1,105 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 0.67 |
Taxes
| Income Tax | -602,358 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +201.94% in the last 52 weeks. The beta is 1.10, so CASBF's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +201.94% |
| 50-Day Moving Average | 3.40 |
| 200-Day Moving Average | 6.17 |
| Relative Strength Index (RSI) | 63.50 |
| Average Volume (20 Days) | 4,055 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CASBF had revenue of 129.15 million and -23.31 million in losses. Loss per share was -0.09.
| Revenue | 129.15M |
| Gross Profit | 96.27M |
| Operating Income | -34.70M |
| Pretax Income | -23.91M |
| Net Income | -23.31M |
| EBITDA | -12.71M |
| EBIT | -34.70M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 456.91 million in cash and 263.67 million in debt, giving a net cash position of 193.24 million.
| Cash & Cash Equivalents | 456.91M |
| Total Debt | 263.67M |
| Net Cash | 193.24M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 684.47M |
| Book Value Per Share | 2.77 |
| Working Capital | 369.53M |
Cash Flow
In the last 12 months, operating cash flow was 8.13 million and capital expenditures -45.92 million, giving a free cash flow of -37.79 million.
| Operating Cash Flow | 8.13M |
| Capital Expenditures | -45.92M |
| Free Cash Flow | -37.79M |
| FCF Per Share | n/a |
Margins
Gross margin is 74.54%, with operating and profit margins of -26.87% and -18.05%.
| Gross Margin | 74.54% |
| Operating Margin | -26.87% |
| Pretax Margin | -18.52% |
| Profit Margin | -18.05% |
| EBITDA Margin | -9.84% |
| EBIT Margin | -26.87% |
| FCF Margin | n/a |
Dividends & Yields
CASBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.65% |
| Shareholder Yield | n/a |
| Earnings Yield | -1.01% |
| FCF Yield | -1.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CASBF has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.18 |
| Piotroski F-Score | 6 |